PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia
· Delayed Price · Currency is IDR 50.00
0.00 (0.00%)
Apr 25, 2025, 3:14 PM WIB
IDX:MEDS Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 6,391 | 22,723 | 37,737 | 75,790 | 87,790 | Upgrade
|
| Revenue Growth (YoY) | -71.88% | -39.79% | -50.21% | -13.67% | 630.26% | Upgrade
|
| Cost of Revenue | 5,866 | 12,086 | 16,712 | 21,812 | 29,182 | Upgrade
|
| Gross Profit | 525.3 | 10,637 | 21,025 | 53,978 | 58,607 | Upgrade
|
| Selling, General & Admin | 9,199 | 13,240 | 16,472 | 19,914 | 9,968 | Upgrade
|
| Operating Expenses | 9,199 | 13,240 | 16,472 | 19,914 | 9,968 | Upgrade
|
| Operating Income | -8,674 | -2,603 | 4,553 | 34,064 | 48,639 | Upgrade
|
| Interest Expense | -482.4 | -663.42 | -759.2 | -180.42 | -10.1 | Upgrade
|
| Interest & Investment Income | 0.82 | 2.85 | 24.42 | 233.16 | 23.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 881.55 | -323.87 | -3,222 | 10.95 | 37.31 | Upgrade
|
| Pretax Income | -8,274 | -3,587 | 596.32 | 34,128 | 48,690 | Upgrade
|
| Income Tax Expense | 259.95 | -17.01 | 359.25 | 7,496 | 10,727 | Upgrade
|
| Net Income | -8,534 | -3,570 | 237.06 | 26,631 | 37,962 | Upgrade
|
| Net Income to Common | -8,534 | -3,570 | 237.06 | 26,631 | 37,962 | Upgrade
|
| Net Income Growth | - | - | -99.11% | -29.85% | 12208.88% | Upgrade
|
| Shares Outstanding (Basic) | 1,563 | 1,563 | 1,373 | 1,250 | 1,250 | Upgrade
|
| Shares Outstanding (Diluted) | 1,563 | 1,563 | 1,373 | 1,250 | 1,250 | Upgrade
|
| Shares Change (YoY) | - | 13.78% | 9.86% | - | 17.63% | Upgrade
|
| EPS (Basic) | -5.46 | -2.29 | 0.17 | 21.31 | 30.37 | Upgrade
|
| EPS (Diluted) | -5.46 | -2.29 | 0.17 | 21.31 | 30.37 | Upgrade
|
| EPS Growth | - | - | -99.19% | -29.85% | 10363.81% | Upgrade
|
| Free Cash Flow | 1,954 | -2,932 | -30,995 | -13,524 | 41,305 | Upgrade
|
| Free Cash Flow Per Share | 1.25 | -1.88 | -22.57 | -10.82 | 33.04 | Upgrade
|
| Gross Margin | 8.22% | 46.81% | 55.71% | 71.22% | 66.76% | Upgrade
|
| Operating Margin | -135.72% | -11.46% | 12.07% | 44.95% | 55.40% | Upgrade
|
| Profit Margin | -133.52% | -15.71% | 0.63% | 35.14% | 43.24% | Upgrade
|
| Free Cash Flow Margin | 30.58% | -12.90% | -82.13% | -17.84% | 47.05% | Upgrade
|
| EBITDA | -4,472 | 985.21 | 7,254 | 35,591 | 49,202 | Upgrade
|
| EBITDA Margin | -69.97% | 4.34% | 19.22% | 46.96% | 56.05% | Upgrade
|
| D&A For EBITDA | 4,202 | 3,588 | 2,701 | 1,527 | 562.22 | Upgrade
|
| EBIT | -8,674 | -2,603 | 4,553 | 34,064 | 48,639 | Upgrade
|
| EBIT Margin | -135.72% | -11.46% | 12.07% | 44.95% | 55.40% | Upgrade
|
| Effective Tax Rate | - | - | 60.25% | 21.96% | 22.03% | Upgrade
|
Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.